Assessing the Relative Importance of Imaging and Serum Biomarkers in Capturing Disability, Cognitive Impairment, and Clinical Progression in Multiple Sclerosis

ABSTRACT The heterogeneity of multiple sclerosis (MS) pathology calls for robust biomarkers to predict disability and progression, particularly progression independent of relapse activity (PIRA). Here, we aimed to identify the most informative MRI and serum biomarkers for predicting clinical outcome...

Descripción completa

Detalles Bibliográficos

Autores principales:	Alessandro Cagol, Pascal Benkert, Sabine Schaedelin, Mario Ocampo‐Pineda, Noemi Montobbio, Po‐Jui Lu, Batuhan Ayci, Antonia Wenger, Alfi Aran Shukur, Kornelius Kaim, Lester Melie‐Garcia, Matthias Weigel, Alessio Signori, Pasquale Calabrese, Ludwig Kappos, Maria Pia Sormani, Jens Kuhle, Cristina Granziera
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wiley 2026-02-01
Colección:	Advanced Science
Materias:	MRI Multiple Sclerosis Progression Independent of Relapse Activity Quantitative MRI Serum Glial Fibrillary Acidic Protein Serum Neurofilament Light Chain
Acceso en línea:	https://doi.org/10.1002/advs.202512946
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!